Search Results for "Reminder Sample Letter Prostate Cancer"

04:37 EDT 2nd August 2014 | BioPortfolio

Original Source: Self-sampling vs. Reminder letter: Effects on cervical cancer screening attendance and coverage in Finland.

Optimising attendance and coverage of organised screening is needed in order to reduce cervical cancer incidence to previous lower levels. In this study all non-participants in organised cervical cancer screening in 2008 in Espoo, Finland were randomised to receive a self-sampling kit (1130 women) or a reminder letter (3030 women). Effects on screening coverage were assessed according to the self-reported previous Pap-smear history of the participants. Participation rate in the self-sampling arm, 29.8%, was...

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...

Prostate Cancer Cellular Vaccine rDNA

Prostate specific membrane antigen PSMA

Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monit...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Prostate Mab

Matching News

Electronic nose sniffs out prostate cancer using urine samples

(Elsevier Health Sciences) We may soon be able to make easy and early diagnoses of prostate cancer by smell. Investigators in Finland have established that a novel noninvasive technique can detect pro...

Noninvasive technique detects prostate cancer using an electronic nose

We may soon be able to make easy and early diagnoses of prostate cancer by smell. Investigators in Finland have established that a novel noninvasive technique can detect prostate cancer using an elect...

Medical News Today: 'eNose' that sniffs out prostate cancer shows promise

Results from a proof of principle study show an electronic nose that sniffs a urine sample can differentiate between prostate cancer and benign disease about as well as a PSA test.

Prostate cancer in young men: an important clinical entity

Current data suggest that early-onset prostate cancer is a distinct clinicopathological subtype of prostate cancer, with more rapid progression to disease-specific death than late-onset prostate cance...

The safety of testosterone supplementation therapy in prostate cancer

Historically, the use of testosterone supplementation therapy (TST) for hypogonadism in men with prostate cancer has been limited by concerns that such treatment might cause progression of this androg...

Prostate cancer: Intriguing data on inflammation and prostate cancer

A new case–control study shows that inflammation on biopsy is associated with diagnosis of prostate cancer. We think a large population-based prospective study, specifically designed to investigate...

A quarter of men drop out of prostate cancer monitoring

A long-term follow up of prostate cancer patients shows that the option of monitoring slow-growing prostate cancer may not be as safe as thought, due to a quarter of men dropping out of the monitoring...

Cancer biology: Studying a new subtype of prostate cancer

A better understanding of a common gene mutation in prostate cancer cells may lead to novel strategies for combating lethal prostate cancer

Matching PubMed Articles

Can microfocal prostate cancer be regarded as low-risk prostate cancer?

Prostate specific antigen (PSA) screening for prostate cancer has become widespread, the prostate biopsy technique has evolved, and the occurrence of low-risk prostate cancer has been increasing. Even...

Markers of prostate cancer stem cells: research advances.

Prostate cancer is one of the most seriously malignant diseases threatening men's health, and the mechanisms of its initiation and progression are not yet completely understood. Recent years have witn...

-174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race.

Interleukin-6 (IL-6), a pro-inflammatory cytokine, is involved in prostate cancer progression, including androgen independence. Serum IL-6 levels also correlate with prostate tumor burden, prostate-sp...

Impact of Psychological Distress on Prostate Cancer Screening in U.S. Military Veterans.

The benefit of routine prostate cancer screening is currently under debate; however, many experts recommend that men with elevated risk for the disease discuss the potential risks and benefits of scre...

Interleukin-30: A novel microenvironmental hallmark of prostate cancer progression.

Metastatic prostate cancer is a leading cause of cancer-related death in men worldwide. We have recently discovered that IL-30 shapes the microenvironment of prostate cancer and tumor-draining lymph n...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement